Advanced search
Publication Cover
Future Medicinal Chemistry Volume 1, 2009 - Issue 7
Submit an article Journal homepage
579
Views
0
CrossRef citations to date
0
Altmetric
Review

Synthesis of Chemically Modified Bioactive Peptides: Recent Advances, Challenges and Developments for Medicinal Chemistry

Soledad Royo Gracia2 Institute for Research in Biomedicine (IRB Barcelona), Parc Científic de Barcelona, Baldiri i Reixac 10, 08028Barcelona, SpainView further author information
,
Katharina Gaus1 Bielefeld University, Department of Chemistry, PO Box 10 01 31, D-33501Bielefeld, GermanyView further author information
&
Norbert Sewald1 Bielefeld University, Department of Chemistry, PO Box 10 01 31, D-33501Bielefeld, GermanyCorrespondence[email protected]
View further author information
Pages 1289-1310 | Published online: 21 Oct 2009

Bibliography

  • Lipinski CA , LombardoF, DominyBW, FeeneyPJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv. Drug Deliv. Rev.46, 3–26 (2001).
  • Marx V . Watching peptide drugs grow up.Chem. Eng. News83, 17–24 (2005).
  • Houben-Weyl Methods of Organic Chemistry (Vol. E22) Synthesis of Peptides and Peptidomimetics . GoodmanM (Ed.). Georg Thieme Verlag, Stuttgart, Germany (2003).
  • Sewald N , JakubkeHD. Peptides: Chemistry and Biology. Wiley-VCH, Weinheim, Germany (2009).
  • Kates SA , SolNA, Albericio,F, BaranyG. Peptides: Design, Synthesis and Biological Activity. BasavaC, AnantharamaiahGM (Eds). Birkhäuser, Boston, MA, USA (1994).
  • Kessler H . Conformation and biological activity of cyclic peptides.Angew. Chem. Int. Ed.21, 512–523 (1982).
  • Werle M , Bernkop-SchnürchA. Strategies to improve plasma half life time of peptide and protein drugs.Amino Acids30, 351–367 (2006).
  • Lien S , LowmanHB. Therapeutic peptides.Trends Biotechnol.21, 556–562 (2003).
  • Hayden C . GnRH analogues: applications in assisted reproductive techniques.Eur. J. Endocrinol.159(Suppl. 1), S17–S25 (2008).
  • Scott CL , HolmbergT. Castration of sex offenders: prisoners’ rights versus public safety.J. Am. Acad. Psychiatry Law31, 502–509 (2003).
  • Weckbecker G , LewisI, AlbertR, SchmidHA, HoyerD, BrunsC. Opportunities in somatostatin research: biological, chemical and therapeutic aspects.Nat. Rev. Drug Disc.2, 999–1017 (2003).
  • Vallette S , SerriO. Octreotide LAR for the treatment of acromegaly.Expert Opin. Drug Metab. Toxicol.4, 783–793 (2008).
  • Lyndrup J , LamontRF. The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.Expert Opin. Investig. Drugs16, 843–853 (2007).
  • Vande Walle J , StocknerM, RaesA, N⊘rgaardJP. Desmopressin 30 years in clinical use: a safety review.Curr. Drug Saf.2, 232–238 (2007).
  • Epstein TG , BernsteinJA. Current and emerging management options for hereditary angioedema in the US.Drugs68, 2561–2573 (2008).
  • Edelman S , MaierH, WilhelmK. Pramlintide in the treatment of diabetes mellitus.BioDrugs22, 375–386 (2008).
  • Nielsen LL , YoungAA, ParkesDG. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of Type 2 diabetes.Regul. Pept.117, 77–88 (2004).
  • Lettino M , ToschiV. Direct antithrombins: new perspectives in cardiovascular medicine.Curr. Med. Chem. Cardiovasc. Hematol. Agents.2, 267–275 (2004).
  • Warkentin TE , KosterA. Bivalirudin: a review.Expert Opin. Pharmacother.6, 1349–1371 (2005).
  • Billich A . Thymosin α1. SciClone Pharmaceuticals.Curr. Opin. Investig. Drugs3, 698–707 (2002).
  • Mandava P , ThiagarajanP, KentTA. Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.Drugs68, 1019–1028 (2008).
  • Xia Z , ChenY, ZhuY, WangF, XuX, ZhanJ. Recombinant ω-conotoxin MVIIA possesses strong analgesic activity.BioDrugs20, 275–281 (2006).
  • Dechantsreiter MA , PlankerE, MathäBet al. N-methylated cyclic RGD peptides as highly active and selective αVβ3 integrin antagonists. J. Med. Chem.42, 3033–3040 (1999).
  • Burke P , DeNardoS, MiersL, LambornK, MatzkuS, DeNardoG. Cilengitide targeting of αVβ3 integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Cancer Res.62, 4263–4272 (2002).
  • Goodman SL , HölzemannG, SulyokGA, KesslerH. Nanomolar small molecule inhibitors for αVβ6, αVβ5, and αVβ3 integrins. J. Med. Chem.45, 1045–1051 (2002).
  • Reardon DA , NaborsLB, StuppR, MikkelsenT. Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme.Expert Opin. Investig. Drugs17, 1225–1235 (2008).
  • Masuoka Y , ShindohN, InamuraN. Histone deacetylase inhibitors from microorganisms: the Astellas experience.Prog. Drug Res.66, 337–359 (2008).
  • Janin YL . Peptides with anticancer use or potential.Amino Acids25, 1–40 (2003).
  • Gilon C , MangC, LohofE, FriedlerA, KesslerH. Synthesis of cyclic peptides. In: Houben-Weyl, Methods of Organic Chemistry (Vol. E22) Synthesis of Peptides and Peptidomimetics. Goodman M (Ed.), Georg Thieme Verlag, Stuttgart, Germany (2003).
  • Davies JS . The cyclization of peptides and depsipeptides.J. Pept. Sci.9, 471–501 (2003).
  • Montalbetti CAGN , FalqueV. Amide bond formation and peptide coupling.Tetrahedron61, 10827–10852 (2005).
  • Valeur E , BradleyM. Amide bond formation: beyond the myth of coupling reagents.Chem. Soc. Rev.38, 606–631 (2009).
  • Meutermans WDF , GoldingSW, BourneGTet al. Synthesis of difficult cyclic peptides by inclusion of a novel photolabile auxiliary in a ring contraction strategy. J. Am. Chem. Soc. 121, 9790–9796 (1999).
  • Miranda LP , MeutermansWDF, SmytheML, AlewoodPF. An activated O-N acyl transfer auxiliary: efficient amide-backbone substitution of hindered ‘difficult’ peptides. J. Org. Chem.65, 5460–5468 (2000).
  • Horton DA , BourneGT, CoughlanJet al. Cyclic tetrapeptides via the ring contraction strategy: chemical techniques useful for their identification. Org. Biomol. Chem. 6, 1386–1395 (2008).
  • Meutermans WDF , BourneGT, GoldingSWet al. Difficult macrocyclizations: new strategies for synthesizing highly strained cyclic tetrapeptides. Org. Lett. 5, 2711–2714 (2003).
  • Shao Y , LuW, KentSBH. A novel method to synthesize cyclic peptides.Tetrahedron Lett.39, 3911–3914 (1998).
  • Taniguchi A , SkwarczynskiM, SohmaYet al. Controlled production of amyloid b peptide from a photo-triggered, water-soluble precursor ‘click peptide’. ChemBioChem 9, 3055–3065 (2008).
  • Coin I , BeyermannM, BienertM. Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences.Nat. Protoc.2, 3247–3256 (2007).
  • Skwarczynski M , KisoY. Application of the O-N intramolecular acyl migration reaction in medicinal chemistry. Curr. Med. Chem.14, 2813–2823 (2007).
  • Tuchscherer G , ChandravarkarA, CamusMSet al. Switch-peptides as folding precursors in self-assembling peptides and amyloid fibrillogenesis. Biopolymers 88, 239–252 (2007).
  • Lécaillon J , GillesP, SubraG, MartinezJ, AmblardM. Synthesis of cyclic peptides via O-N-acyl migration. Tetrahedron Lett.49, 4674–4676 (2008).
  • Miller SJ , BlackwellHE, GrubbsRH. Application of ring-closing metathesis to the synthesis of rigidified amino acids and peptides.J. Am. Chem. Soc.118, 9606 (1996).
  • Stymiest JL , MitchellBF, WongS, VederasJC. Synthesis of biologically active dicarba analogues of the peptide hormone oxytocin using ring-closing metathesis.Org. Lett.5, 47–49 (2003).
  • Stymiest JL , MitchellBF, WongS, VederasJC. Synthesis of oxytocin analogues with replacement of sulfur by carbon gives potent antagonists with increased stability.J. Org. Chem.70, 7799–7809 (2005).
  • Berezowska I , ChungNN, LemieuxC, WilkesBC, SchillerPW. Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH2 retain high opioid activity. J. Med. Chem.50, 1414–1417 (2007).
  • Mollica A , GuardianiG, DavisPet al. Synthesis of stable and potent δ/µ opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-PheD-Cys]-OH by ring-closing metathesis. J. Med. Chem. 50, 3138–3142 (2007).
  • Miles SM , LeatherbarrowRJ, MarsdenSP, CoatsWJ. Synthesis and bio-assay of RCM-derived Bowman-Birk inhibitor analogues.Org. Biomol. Chem.2, 281–283 (2005).
  • Robinson AJ , ElaridiJ, Van Lierop BJ, Mujcinovic S, Jackson E. Microwave-assisted RCM for the synthesis of carbocyclic peptides. J. Pept. Sci.13, 280–285 (2007).
  • Pattabiraman VR , StymiestJL, DerksenDJ, MartinNI, VederasJC. Multiple on-resin olefin metathesis to form ring-expanded analogues of the lantibiotic peptide, lacticin 3147 A2.Org. Lett.9, 699–702 (2007).
  • Ghalit N , ReichweinJF, HilbersHW, BreukinkE, RijkersDTS, LiskampRMJ. Synthesis of bicyclic alkene-/alkane-bridged nisin mimics by ring-closing metathesis and their biochemical evaluation as lipid II binders: toward the design of potential novel antibiotics.ChemBioChem18, 1540–1554 (2007).
  • Ghalit N , KemminkJ, HilbersHW, VersluisC, RijkersDTS, LiskampRMJ. Step-wise and pre-organization induced synthesis of a crossed alkene-bridged nisin Z DE-ring mimic by ring-closing metathesis.Org. Biomol. Chem.5, 924–934 (2007).
  • Hruby VJ . Designing peptide receptor agonists and antagonists.Nat. Rev. Drug Discov.1, 847–858 (2002).
  • Schmiedeberg N , KesslerH. Reversible backbone protection enables combinatorial solid-phase ring-closing metathesis reaction (RCM) in peptides.Org. Lett.4, 59–62 (2001).
  • Brik A . Metathesis in peptides and peptidomimetics.Adv. Synth. Catal.350, 1661–1675 (2008).
  • Dekker FJ , de Mol NJ, Fischer MJE, Kemmink J, Liskamp RMJ. Role of solution conformation and flexibility of short peptide ligands that bind to the p56(lck) SH2 domain. Org. Biomol. Chem.1, 3297–3303 (2003).
  • Wang D , LiuM, AroraPS. Inhibition of HIV-1 fusion by hydrogen-bond-surrogate-based α helices.Angew. Chem. Int. Ed.47, 1879–1882 (2008).
  • Boyle TP , BremnerJB, CoatesJet al. New cyclic peptides via ring-closing metathesis reactions and their anti-bacterial activities. Tetrahedron 64, 11270–11290 (2008).
  • Hossain MA , RosengrenKJ, ZhangSet al. Solid phase synthesis and structural analysis of novel A-chain dicarba analogs of human relaxin-3 (INSL7) that exhibit full biological activity. Org. Biomol. Chem. 7, 1547–1553 (2009).
  • Harris PWR , BrimbleMA. Synthesis of macrocyclic analogues of the neuroprotective agent glycyl-l-prolyl-l-glutamic acid (GPE).Org. Biomol. Chem.4, 2696–2709 (2006).
  • Lawrence J , JourdanM, ValléeY, BlandinV. Peptide cyclization via ring-closing metathesis: the N-alkenoxy peptide approach. Org. Biomol. Chem.6, 4575–4581 (2008).
  • Illesinghe J , GuoCX, GarlandRet al. Metathesis assisted synthesis of cyclic peptides. Chem. Commun. 3, 295–297 (2009).
  • Angell YL , BurgessK. Peptidomimetics via copper-catalyzed azide–alkyne cycloadditions.Chem. Soc. Rev.36, 1674–1689 (2007).
  • Roice M , JohannsenI, MeldalM. High capacity poly(ethylene glycol) based amino polymers for peptide and organic synthesis.QSAR Comb. Sci.23, 662–673 (2004).
  • Cantel S , Le Chevalier IsaadA, ScrimaMet al. Synthesis and conformational analysis of a cyclic peptide obtained via i to i+4 intramolecular sidechain to sidechain azide-alkyne 1,3-dipolar cycloaddition. J. Org. Chem.73, 5663–5674 (2008).
  • Le Chevalier Isaad A , PapiniAM, ChorevM, RoveroP. Side chain-to-side-chain cyclization by click reaction.J. Pept. Sci.15, 451–454 (2009).
  • Bock VD , SpeijerD, HiemstraH, van Maarseveen JH. 1,2,3-triazoles as peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide mimics. Org. Biomol. Chem.5, 971–975 (2007).
  • Liu Y , ZhangL, WanJ, LiY, XuY, PanY. Design and synthesis of cyclo[-Arg-Gly-Asp-ψ(triazole)-Gly-Xaa-] peptide analogues by click chemistry.Tetrahedron64, 10728–10734 (2008).
  • Punna S , KuzelkaJ, WangQ, FinnMG. Head-to-tail peptide cyclodimerization by copper-catalyzed azide-alkyne cycloaddition.Angew. Chem. Int. Ed.44, 2215–2220 (2005).
  • van Maarseveen JH , HorneWS, GhadiriMR. Efficient route to C-2 symmetric heterocyclic backbone modified cyclic peptides.Org. Lett.7, 4503–4506 (2005).
  • Angell Y , BurgessK. Ring closure to β-turn mimics via copper-catalyzed azide/alkyne cycloadditions.J. Org. Chem.70, 9595–9598 (2005).
  • Goncalves V , GautierB, RegazzettiAet al. On-resin cyclization of peptide ligands of the vascular endothelial growth factor receptor 1 by copper(I)-catalyzed 1,3-dipolar azide–alkyne cycloaddition. Bioorg. Med. Chem. Lett. 17, 5590–5594 (2007).
  • Turner RA , OliverAG, LokeyRS. Click chemistry as a macrocyclization tool in the solid-phase synthesis of small cyclic peptides.Org. Lett.9, 5011–5014 (2007).
  • Bock VD , PerciaccanteR, JansenTP, HiemstraH, van Maarseveen JH. Click chemistry as a route to cyclic tetrapeptide analogues: synthesis of cyclo-[Pro-Val-ψ(triazole)-Pro-Tyr]. Org. Lett.8, 919–922 (2006).
  • Himo F , LovellT, HilgrafRet al. Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. J. Am. Chem. Soc. 127, 210–216 (2005).
  • Horne WS , OlsenCA, BeierleHM, MonteroA, GhadiriMR. Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides.Angew. Chem. Int. Ed.48, 4718–4724 (2009).
  • Beierle JM , HorneWS, van Maarseveen JH, Waser B, Reubi JC, Ghadiri MR. Conformationally heterogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues. Angew. Chem. Int. Ed.48, 4725–4729 (2009).
  • Köhn M , BreinbauerR. The Staudinger ligation – a gift to chemical biology.Angew. Chem. Int. Ed.43, 3106–3116 (2004).
  • Nilsson BL , KiesslingLL, RainesRT. Staudinger ligation: a peptide from a thioester and azide.Org. Lett.2, 1939–1941 (2000).
  • Saxon E , ArmstrongJI, BertozziCR. A ‘traceless’ Staudinger ligation for the chemoselective synthesis of amide bonds.Org. Lett.2, 2141–2143 (2000).
  • Soellner MB , TamA, RainesRT. Staudinger ligation of peptides at non-glycyl residues.J. Org. Chem.71, 9824–9830 (2006).
  • Soellner MB , NilssonBL, RainesRT. Reaction mechanism and kinetics of the traceless Staudinger ligation.J. Am. Chem. Soc.128, 8820–8828 (2006).
  • Liu L , Hong Z-Y, Wong C-H. Convergent glycopeptide synthesis by traceless Staudinger ligation and enzymatic coupling. ChemBioChem7, 429–432 (2006).
  • Tam A , SoellnerMB, RainesRT. Water-soluble phosphinothiols for traceless Staudinger ligation and integration with expressed protein ligation.J. Am. Chem. Soc.129, 11421–11430 (2007).
  • Tam A , SoellnerMB, RainesRT. Electronic and steric effects on the rate of the traceless Staudinger ligation.Org. Biomol. Chem.6, 1173–1175 (2008).
  • David O , MeesterWJN, BieräugelH, HiemstraH, van Maarseveen JH. Intramolecular Staudinger ligation: a powerful ring-closure method to form medium-sized lactams. Angew. Chem. Int. Ed.42, 4373- 4375 (2003).
  • Masson G , den Hartog T, Schoemaker HE, Hiemstra H, van Maarseveen JH. Intramolecular Staudinger ligation towards biaryl-containing lactams. Synlett6, 865–868 (2006).
  • Kleineweischede R , HackenbergerCPR. Chemoselective peptide cyclization by traceless Staudinger ligation.Angew. Chem. Int. Ed.47, 5984–5988 (2008).
  • Friedler A , FriedlerD, LuedtkeNWet al. Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif. J. Biol. Chem. 275, 23783–23789 (2000).
  • Hess S , OvadiaO, ShalevDEet al. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability. J. Med. Chem. 50, 6201–6211 (2007).
  • Gazal S , GellermanG, ZivOet al. Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units. J. Med. Chem. 45, 1665–1671 (2002).
  • Zeltser I , Ben-AzizO, ScheflerIet al. Insect neuropeptide antagonist. Part II. Synthesis and biological activity of backbone cyclic and precyclic PBAN antagonists. J. Pept. Res. 58, 275–284 (2001).
  • Gilon C , ZeltserI, DanielSet al. Rationally designed neuropeptide antagonists: a novel approach for generation of environmentally friendly insecticides. Invertebr. Neurosci. 3, 245–250 (1997).
  • Qvit N , ReuveniH, GazalSet al. Synthesis of a novel macrocyclic library: discovery of an IGF-1R inhibitor. J. Comb. Chem. 10, 256–266 (2008).
  • Weide T , ModlingerA, KesslerH. Spatial screening for the identification of the bioactive conformation of integrin ligands.Top. Curr. Chem.272, 1–50 (2007).
  • Haubner R , FinsingerD, KesslerH. Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors of the αVβ3 integrin for a new cancer therapy. Angew. Chem. Int. Ed.36, 1374–1389 (1997).
  • Boer J , GottschlingD, SchusterAet al. Design and synthesis of potent and selective α4β7 integrin antagonists. J. Med. Chem. 44, 2586–2592 (2001).
  • Tucker GC . Integrins: molecular targets in cancer therapy.Curr. Oncol. Rep.8, 96–103 (2006).
  • Bächle D , LoersG, GuthöhrleinEW, SchachnerM, SewaldN. Glycomimetic cyclopeptides stimulate neurite outgrowth.Angew. Chem. Int. Ed.45, 6582–6585 (2006).
  • Simova O , IrintchevA, MehannaAet al. Carbohydrate mimics promote functional recovery after peripheral nerve repair. Ann. Neurol. 60, 430–437 (2006).
  • Aguilar MI , PurcellAW, DeviRet al. β-Amino acid-containing hybrid peptides – new opportunities in peptidomimetics. Org. Biomol. Chem. 5, 2884–2890 (2007).
  • Joshi RM , ChauhanCH. Synthesis of peptides based on α,β-didehydro α-amino acids. In: Houben-Weyl, Methods of Organic Chemistry (Vol. E22) Synthesis of Peptides and Peptidomimetics. GoodmanM (Ed.). Georg Thieme Verlag, Stuttgart, Germany (2003).
  • Mathur P , RamakumarS, ChauhanVS. Peptide design using α,β-dehydro amino acids: from β-turns to helical hairpins. Biopolymers (Pept. Sci.)76, 150–161 (2004).
  • Toniolo C , CrismaM, FormaggioF, PeggionC. Control of peptide conformation by the Thorpe-Ingold effect (C-α-tetrasubstitution).Biopolymers (Pept. Sci.)60, 396–419 (2001).
  • Wu YD , HanW, WangDP, GaoY, ZhaoYL. Theoretical analysis of secondary structures of β-peptides.Acc. Chem. Res.41, 1418–1427 (2008).
  • Chatterjee S , RoyRS, BalaramSR. Expanding the polypeptide backbone: hydrogen-bonded conformations in hybrid polypeptides containing the higher homologues of α-amino acids.J. R. Soc. Interface4, 587–606 (2007).
  • Schumann F , MüllerA, KokschM, MüllerG, SewaldN. Are β-amino acids γ-turn mimetics? Exploring a new design principle for bioactive cyclopeptides.J. Am. Chem. Soc.122, 12009–12010 (2000).
  • Maleševic M , MajerZ, VassEet al. Spectroscopic detection of pseudo-turns in homodetic cyclic penta- and hexapeptides comprising β-homoproline. Int. J. Pept. Res. Ther. 12, 165–177 (2006).
  • Urman S , GausK, YangYet al. The constrained amino acid β-Acc confers potency and selectivity to integrin ligands. Angew. Chem. Int. Ed. Engl. 46, 3976–3978 (2007).
  • Hamada Y , ShioiriT. Recent progress of the synthetic studies of biologically active marine cyclic peptides and depsipeptides.Chem. Rev.105, 4441–4482 (2005).
  • Harris KS , CaseyJL, ColeyAMet al. Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning. J. Biol. Chem. 284, 9361–9371 (2009).
  • Teixidó M , ZuritaE, MalakoutikhahM, TarragóT, GiraltE. Diketopiperazines as a tool for the study of transport across the blood–brain barrier (BBB) and their potential use as BBB-shuttles.J. Am. Chem. Soc.129, 11802–11813 (2007).
  • Bergseng E , XiaJ, KimCY, KhoslaC, SollidLM. Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the Celiac disease-associated HLA-DQ2 molecule.J. Biol. Chem.280, 21791–21796 (2005).
  • Conradi R , HilgersA, HoN, BurtonP. The influence of peptide structure on transport across Caco-2 cells. II. Peptide-bond modification which results in improved permeability.Pharm. Res.9, 435–439 (1992).
  • Sagan S , KaroyanP, LequinO, Chassaing,G, LavielleS. N- and Cα-methylation in biologically active peptides: synthesis, structural and functional aspects Curr. Med. Chem.11, 2799–2822 (2004).
  • Linde Y , OvadiaO, SafraiEet al. Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides. Biopolymers 90, 671–682 (2008).
  • Rajeswaran WG , HocartSJ, MurphyWA, TaylorJE, CoyDH. N-methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity. J. Med. Chem.44, 1416–1421 (2001).
  • Rajeswaran WG , HocartSJ, MurphyWA, TaylorJE, CoyDH. Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonists. J. Med. Chem.44, 1305–1311 (2001).
  • Chatterjee J , OvadiaO, ZahnGet al. Multiple N-methylation by a designed approach enhances receptor selectivity. J. Med. Chem. 50, 5878–5881 (2007).
  • Biron E , ChatterjeeJ, OvadiaOet al. Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogs. Angew. Chem. Int. Ed. 47, 2595–2599 (2008).
  • Teixidó M , AlbericioF, GiraltE. Solid-phase synthesis and characterization of N-methyl-rich peptides. J. Peptide Res.65, 153–166 (2005).
  • Sewald N . Efficient, racemization-free peptide coupling of N-alkyl amino acids by using amino acid chlorides generated in situ – total syntheses of the cyclopeptides cyclosporin O and omphalotin A. Angew. Chem. Int. Ed.41, 4661–4663 (2002).
  • Biron E , KesslerH. Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis. J. Org. Chem.70, 5183–5189 (2005).
  • Biron E , ChatterjeeJ, KesslerH. Optimized selective N-methylation of peptides on solid support. J. Pept. Sci.12, 213–219 (2006).
  • Demmer O , DijkgraafI, SchotteliusM, WesterHJ, KesslerH. Introduction of functional groups into peptides via N-alkylation. Org. Lett.10, 2015–2018 (2008).
  • Chatterjee J , MierkeD, KesslerH. N-methylated cyclic pentaalanine peptides as template structures. J. Am. Chem. Soc.128, 15164–15172 (2006).
  • Chatterjee J , MierkeDF, KesslerH. Conformational preference and potential templates of N-methylated cyclic pentaalanine peptides. Chem. Eur. J.14, 1508–1517 (2008).
  • Chatterjee J , GilonC, HoffmanA, KesslerH. N-methylation of peptides: a new perspective in medicinal chemistry. Acc. Chem. Res.41, 1331–1342 (2008).
  • Tulla-Puche J , MarcucciE, Prats-AlfonsoE, Bayó-PuxanN, AlbericioF. NMe amide as a synthetic surrogate for the thioester moiety in thiocoraline. J. Med. Chem.52, 834–839 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.